Thank you for joining us at the Alliance for Cancer Gene Therapy Summit 2024. 

ACGT Summit 2024 is an annual invitation-only event in recognition of ACGT’s two decades of advancing research to develop curative cell and gene therapies for cancer.

This day-long event brings many of ACGT’s Research Fellows together with our esteemed Scientific Advisory Council, Board of Directors, Alliance Partners and other important thought-leaders in the cell and gene therapy field to engage in a series of panels and discussions designed to forward the development of new life-saving cell and gene therapies focusing on solid tumors. 
ACGT’s alliance of researchers, clinicians, companies, and non-profit partners have the opportunity to hear from the trailblazers driving clinical advances. Attendees participate in working sessions focused on breaking down barriers, enabling collaborations and expediting breakthroughs. 

ACGT Summit 2024 Sponsors

We are grateful to our 2024 sponsors and thank them for their support!


Featured Speakers

E. Antonio Chiocca, MD, PhD, Brigham and Women’s Hospital

Juan Fueyo, MD, MD, Anderson Cancer Center

Carl H. June, MD, University of Pennsylvania Abramson Cancer Center

Bruce Levine, PhD, University of Pennsylvania Abramson Cancer Center

Michael T. Lotze, MD, University of Pittsburgh

Crystal Mackall, MD, Stanford University

Hideho Okada, MD, PhD, University of California San Francisco

Katy Rezvani, MD, PhD, MD, Anderson Cancer Center

Stephen J. Russell, MD, PhD, Vyriad

George D. Yancopoulos, MD, PhD, Regeneron Pharmaceuticals